Pure delta-9-tetrahydrocannabinol and its combination with cannabidiol in treatment-resistant Tourette syndrome: A case report
The International Journal of Psychiatry in Medicine · 2019-03 · 54 (2) · 150-156
DOI: 10.1177/0091217418791455 ↗Kurz gefasst
Fallbericht in der Zeitschrift The International Journal of Psychiatry in Medicine, online erschienen am 30.07.2018. Verfasst von Eva-Maria Pichler und 3 weiteren Autor:innen. Beteiligte Einrichtung: 1 Department of Psychiatry and Psychotherapy, Psychiatric Services Aargau AG, Brugg, Switzerland. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Objectives
Anecdotal reports and preliminary studies suggest a therapeutic potential of cannabis in Tourette syndrome. We report the case of a female patient suffering from treatment-resistant Tourette syndrome.
Methods
Guideline-directed antipsychotic treatment with risperidone and aripiprazole as well as pure delta-9-tetrahydrocannabinol had no significant effect on Tourette syndrome symptomatology.
Results
Following administration of a daily dosage of 10 mg delta-9-tetrahydrocannabinol combined with 20 mg cannabidiol (CBD), the patient showed a rapid and highly significant improvement in the Yale Global Tic Severity Scale.
Conclusions
It can be speculated whether the beneficial effects may rely on the pharmacological properties of cannabidiol.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1 Department of Psychiatry and Psychotherapy, Psychiatric Services Aargau AG, Brugg, Switzerland.
- 2 Department for Psychiatry, Psychotherapy and Psychosomatics, University of Zurich, Zurich, Switzerland.
ORCID-Profile: Eva-Maria Pichler
Zitieren
APA
Pichler, E. M., Kawohl, W., Seifritz, E., & Roser, P. (2019). Pure delta-9-tetrahydrocannabinol and its combination with cannabidiol in treatment-resistant Tourette syndrome: A case report. The International Journal of Psychiatry in Medicine, 54(2), 150-156. https://doi.org/10.1177/0091217418791455
Vancouver
Pichler EM, Kawohl W, Seifritz E, Roser P. Pure delta-9-tetrahydrocannabinol and its combination with cannabidiol in treatment-resistant Tourette syndrome: A case report. The International Journal of Psychiatry in Medicine. 2019;54(2):150-156. doi:10.1177/0091217418791455
BibTeX
@article{Pichler2019,
author = {Pichler, Eva-Maria and Kawohl, Wolfram and Seifritz, Erich and Roser, Patrik},
title = {Pure delta-9-tetrahydrocannabinol and its combination with cannabidiol in treatment-resistant Tourette syndrome: A case report},
journal = {The International Journal of Psychiatry in Medicine},
year = {2019},
volume = {54},
number = {2},
pages = {150--156},
doi = {10.1177/0091217418791455}
}
EUVIMED